These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications. Hong S; Banks WA Brain Behav Immun; 2015 Mar; 45():1-12. PubMed ID: 25449672 [TBL] [Abstract][Full Text] [Related]
7. Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals. Clark US; Cohen RA Curr Opin Investig Drugs; 2010 Aug; 11(8):884-900. PubMed ID: 20721831 [TBL] [Abstract][Full Text] [Related]
8. Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disorders. Gendelman HE; Gelbard HA Curr Opin HIV AIDS; 2014 Nov; 9(6):585-90. PubMed ID: 25226025 [TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus-associated neurocognitive disorder: pathophysiology in relation to drug addiction. Nath A Ann N Y Acad Sci; 2010 Feb; 1187():122-8. PubMed ID: 20201849 [TBL] [Abstract][Full Text] [Related]
10. Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort. Robinson-Papp J; Byrd D; Mindt MR; Oden NL; Simpson DM; Morgello S; Arch Neurol; 2008 Aug; 65(8):1096-101. PubMed ID: 18695060 [TBL] [Abstract][Full Text] [Related]
11. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment. Chan P; Brew BJ Curr HIV/AIDS Rep; 2014 Sep; 11(3):317-24. PubMed ID: 24966139 [TBL] [Abstract][Full Text] [Related]
12. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease. Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738 [TBL] [Abstract][Full Text] [Related]
13. Imaging correlates of the blood-brain barrier disruption in HIV-associated neurocognitive disorder and therapeutic implications. Chaganti J; Marripudi K; Staub LP; Rae CD; Gates TM; Moffat KJ; Brew BJ AIDS; 2019 Oct; 33(12):1843-1852. PubMed ID: 31274535 [TBL] [Abstract][Full Text] [Related]
14. Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus. Bogoch II; Davis BT; Venna N J Infect; 2011 Sep; 63(3):236-9. PubMed ID: 21658774 [TBL] [Abstract][Full Text] [Related]
15. Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics. Peluso MJ; Spudich S Curr HIV/AIDS Rep; 2014 Sep; 11(3):353-62. PubMed ID: 25063356 [TBL] [Abstract][Full Text] [Related]